Show simple item record

dc.contributor.authorMac Aogáin, M
dc.contributor.authorNarayana, JK
dc.contributor.authorTiew, PY
dc.contributor.authorAli, NABM
dc.contributor.authorYong, VFL
dc.contributor.authorJaggi, TK
dc.contributor.authorLim, AYH
dc.contributor.authorKeir, HR
dc.contributor.authorDicker, AJ
dc.contributor.authorThng, KX
dc.contributor.authorTsang, A
dc.contributor.authorIvan, FX
dc.contributor.authorPoh, ME
dc.contributor.authorOriano, M
dc.contributor.authorAliberti, S
dc.contributor.authorBlasi, F
dc.contributor.authorLow, TB
dc.contributor.authorOng, TH
dc.contributor.authorOliver, B
dc.contributor.authorGiam, YH
dc.contributor.authorTee, A
dc.contributor.authorKoh, MS
dc.contributor.authorAbisheganaden, JA
dc.contributor.authorTsaneva-Atanasova, K
dc.contributor.authorChalmers, JD
dc.contributor.authorChotirmall, SH
dc.date.accessioned2021-04-08T10:05:12Z
dc.date.issued2021-04-05
dc.description.abstractBronchiectasis, a progressive chronic airway disease, is characterized by microbial colonization and infection. We present an approach to the multi-biome that integrates bacterial, viral and fungal communities in bronchiectasis through weighted similarity network fusion (https://integrative-microbiomics.ntu.edu.sg). Patients at greatest risk of exacerbation have less complex microbial co-occurrence networks, reduced diversity and a higher degree of antagonistic interactions in their airway microbiome. Furthermore, longitudinal interactome dynamics reveals microbial antagonism during exacerbation, which resolves following treatment in an otherwise stable multi-biome. Assessment of the Pseudomonas interactome shows that interaction networks, rather than abundance alone, are associated with exacerbation risk, and that incorporation of microbial interaction data improves clinical prediction models. Shotgun metagenomic sequencing of an independent cohort validated the multi-biome interactions detected in targeted analysis and confirmed the association with exacerbation. Integrative microbiomics captures microbial interactions to determine exacerbation risk, which cannot be appreciated by the study of a single microbial group. Antibiotic strategies probably target the interaction networks rather than individual microbes, providing a fresh approach to the understanding of respiratory infection.en_GB
dc.description.sponsorshipSingapore Ministry of Health National Medical Research Councilen_GB
dc.description.sponsorshipClinician-Scientist Individual Research Granten_GB
dc.description.sponsorshipBiological and Environmental Life Sciences (NIMBELS)en_GB
dc.description.sponsorshipBritish Lung Foundationen_GB
dc.description.sponsorshipScottish Government Chief Scientist Officeen_GB
dc.description.sponsorshipEngineering and Physical Sciences Research Council (EPSRC)en_GB
dc.identifier.citationPublished online 5 April 2021en_GB
dc.identifier.doi10.1038/s41591-021-01289-7
dc.identifier.grantnumberNMRC/TA/0048/2016en_GB
dc.identifier.grantnumberMOH-000141en_GB
dc.identifier.grantnumberNIM/03/2018en_GB
dc.identifier.grantnumberSCAF/17/03en_GB
dc.identifier.grantnumberEP/N014391/1en_GB
dc.identifier.urihttp://hdl.handle.net/10871/125306
dc.language.isoenen_GB
dc.publisherNature Researchen_GB
dc.relation.urlhttps://github.com/translational-respiratory-lab/The_Interactome/tree/master/Dataen_GB
dc.relation.urlhttps://github.com/translational-respiratory-lab/The_Interactomeen_GB
dc.rights.embargoreasonUnder embargo until 5 October 2021 in compliance with publisher policyen_GB
dc.rights© The Author(s), under exclusive licence to Springer Nature America, Inc. 2021en_GB
dc.titleIntegrative microbiomics in bronchiectasis exacerbationsen_GB
dc.typeArticleen_GB
dc.date.available2021-04-08T10:05:12Z
dc.identifier.issn1546-170X
dc.descriptionThis is the author accepted manuscript. The final version is available from Nature Research via the DOI in this recorden_GB
dc.descriptionData availability: All of the sequence data described in this study have been uploaded to the NCBI SRA under project accession PRJNA590225. Publicly available taxonomic and functional databases are referenced by short-read sequence classification tools used in this study as further described in the Nature Research Reporting Summary. Other associated data, including bacterial, fungal and viral profiles for all of the patients, as well as patient clinical attributes, are available at https://github.com/translational-respiratory-lab/The_Interactome/tree/master/Data.en_GB
dc.descriptionCode availability: All code required for generation of the presented results, with accompanying documentation, are available at the study’s online code repository (https://github.com/translational-respiratory-lab/The_Interactome).en_GB
dc.identifier.journalNature Medicineen_GB
dc.rights.urihttp://www.rioxx.net/licenses/all-rights-reserveden_GB
dcterms.dateAccepted2021-02-16
rioxxterms.versionAMen_GB
rioxxterms.licenseref.startdate2021-04-05
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2021-04-05T15:52:01Z
refterms.versionFCDVoR
refterms.panelBen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record